Nuveen’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$406K Buy
52,542
+320
+0.6% +$2.33K ﹤0.01% 2917
2025
Q4
$320K Hold
52,222
﹤0.01% 3029
2025
Q3
$962K Hold
52,222
﹤0.01% 2642
2025
Q2
$679K Sell
52,222
-7,756
-13% -$91.7K ﹤0.01% 2775
2025
Q1
$635K Sell
59,978
-27,119
-31% -$430K ﹤0.01% 2823
2024
Q4
$1.48M Sell
87,097
-10,221
-11% -$192K ﹤0.01% 2515
2024
Q3
$2.26M Buy
97,318
+7,675
+9% +$164K ﹤0.01% 2351
2024
Q2
$2.18M Sell
89,643
-34,222
-28% -$1.04M ﹤0.01% 2342
2024
Q1
$4.18M Sell
123,865
-70,817
-36% -$2.51M ﹤0.01% 2081
2023
Q4
$6.14M Buy
194,682
+336
+0.2% +$7.99K ﹤0.01% 1864
2023
Q3
$4.97M Buy
194,346
+6,014
+3% +$185K ﹤0.01% 1871
2023
Q2
$5.4M Buy
188,332
+40,168
+27% +$1.09M ﹤0.01% 1876
2023
Q1
$3.55M Buy
148,164
+79,617
+116% +$1.43M ﹤0.01% 2075
2022
Q4
$1.16M Sell
68,547
-41,541
-38% -$724K ﹤0.01% 2629
2022
Q3
$1.63M Buy
110,088
+1,482
+1% +$24.9K ﹤0.01% 2506
2022
Q2
$1.71M Buy
108,606
+17,148
+19% +$337K ﹤0.01% 2513
2022
Q1
$2.24M Sell
91,458
-3,467
-4% -$88.5K ﹤0.01% 2453
2021
Q4
$3.51M Buy
94,925
+4,292
+5% +$175K ﹤0.01% 2294
2021
Q3
$4.93M Sell
90,633
-37,539
-29% -$1.68M ﹤0.01% 2218
2021
Q2
$4.34M Buy
128,172
+49,906
+64% +$1.69M ﹤0.01% 2323
2021
Q1
$3.23M Sell
78,266
-17,947
-19% -$1.07M ﹤0.01% 2382
2020
Q4
$4.17M Buy
96,213
+23,936
+33% +$1.62M ﹤0.01% 2166
2020
Q3
$3.1M Buy
72,277
+9,745
+16% +$484K ﹤0.01% 2160
2020
Q2
$2.92M Buy
+62,532
New +$2.16M ﹤0.01% 2171

Other funds holding ARCT